MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Torax Medical
Parents
*Portfolio Companies: Accuitive Medical Ventures
Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Industry: Minnesota
Venture Capital: Series D
Children
Focused on the Minimally Invasive Treatment of Gastroesophageal Reflux Disease, Raised $18 Million in 2009, $10 Million in 2005 and Another $3.5 Million in 2004.
Industry: Medical Devices & Equipment Sub-Industry: Surgical Devices
Investors include Thomas McNerney & Partners, Sanderling Ventures, Mayo Medical Ventures and Accuitive Medical Ventures.
Shoreview, Minnesota
Torax Medical is developing an implantable device to strengthen the esophageal sphincter for the treatment of gastro-esophageal reflux disease (GERD).
Torax Medical Raises $4 Million in Quest for $8 Million (2011)
Torax pulls in $30M to market gastro device (2012)